Director · AVITA Medical, Inc. · AVITA Medical, Inc. — Stock Options (Right to Buy)
Side
A
Value
—
Shares
16.1K
Price
—
Executed
Jan 20, 2026
Disclosed
Jun 4, 2026
Disclosure timeline135 days from execution to publication · legal deadline 2 business days
Jan 20 executedJun 4, 2026 disclosed
RCEL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+15 / 15
Disclosed 97 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
AVITA Medical, Inc. — Stock Options (Right to Buy)
Ticker
RCEL
Shares
16.1K
Price per share
$0
Execution date (reported)
Jan 20, 2026
Owned after transaction
16.1K shares
Days from execution to publication
135
What this establishes
Crowe Suzanne filed this Form 4 reporting a grant or award of RCEL on Jan 20, 2026. It became public on Jun 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Crowe Suzannecik:0001816242
Issuer
AVITA Medical, Inc.cik:0001762303
Revision history · 0
No field has changed since this record was first ingested.
